Dtermination of coumarin metabolism in Turkish population

Abstract

Cytochrome P450 2A6 is an important human hepatic P450 which activates precarcinogens and oxidizes some drug constituents such as coumarin, halothane, and the major nicotine C-oxidase. Genetic polymorphism exists in the CYP2A6 gene. CYP2A6*1 (wild type)is responsible for the 7-hydroxylation of coumarin. The point mutation (T to A) in codon 160 leads to a single amino acid substitution (Leu to His) and the resulting protein, CYP2A*2 is unable to 7-hydroxylate coumarin. Gene conversion in exons 3, 6, and 8 between the CYP2A6 and the CYP2A7 genes creates another variant, CYP2A6*3. In this study, healthy male and female Turkish volunteers (n = 50) were administered 2 mg coumarin, and urine samples were analyzed for their content of the coumarin metabolite, 7-hydroxycoumarin (70HC), by high-performance liquid chromatography (HPLC). Genetic polymorphism for CYP2A6 was detected by using two-step polymerase chain reaction (PCR) to identify CYP2A6*1, CYP2A6*2, and CYP2A6*3 in 13 of these subjects. The percentage of the dose excreted of total 70HC in relation to CYP2A6 genotype and excretion of nicotine/cotinine was also evaluated to demonstrate the role of CYP2A6 in nicotine metabolism. The majority of Turkish subjects (68%) excreted less than 60% of the 2-mg dose as coumarin metabolite. The allelic frequencies were detected as 0.88 for CYP2A6*1 allele; 0.12 for CYP2A6*3 allele in 13 individuals. No heterozygous and homozygous individuals were identified for the CYP2A6*2 allelic variant. Phenotyping and genotyping for drug metabolizing enzymes are of great importance in studies correlating precarcinogen activation or drug metabolism to the CYP2A6 genotype in smoking behavior when populations are investigated.

Keywords

coumarin coumarin 7-hydroxylation CYP2A6 interindividual variabilit

References

1 Yun C , Shimida T , Guengerich FP . Purification and characterization of human liver microsomal cytochrome P450 2A6 . Mol Pharmacol 1991; 40: 679-685 .

2 Oscarson M , McLellan RA , Gullsten H , Gun-Ying Y , Lang MA , Bernal ML , Sinues B , Hirvonen A , Ranuio H , Pelkonen O , Ingelman-Sundberg M Characterization and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population . FEBS Lett 1999; 448: 105-110 .

3 Oscarson M , McLellan RA , Gullsten H , Agundez JAG , Benitez J , Rautio A , Ranuio H , Pelkonen O , Ingelman-Sundberg M Identification and characterization of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism . FEBS Lett 1999; 460: 321-327 .

4 Messina ES , Tyndale RF , Sellers EM . A major role for CYP2A6 in nicotine Coxidation by human liver microsomes . J Pharmacol Exp Ther 1997; 282: 1608-1614 .

5 Yamazaki H , Inoue K , Hashimoto M , Shimada T Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes . Arch Toxicol 1999; 73: 65-70 .

6 Fernandez-Salguero P , Gonzalez FJ . The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis . Pharmacogenetics 1995; 5: 123-128 .

7 Raunio H , Syngelma T , Pasanen M , Juvonen R , Honkakoshi P , Kairalvoma MA , Sotaniemi E , Lang MA , Pelkonen O Immunochemical and catalytic studies on hepatic coumarin 7-hydroxylase in man, rat and mouse . Biochem Pharmacol 1988; 378: 3889-3895 .

8 Miles JS , Mclaren AW , Forrester LM , Glancey MJ , Lang MA , Wolf CR . Identification of the human liver cytochrome P450 responsible for coumarin 7-hydroxylase activity . Biochem J 1990; 267: 365-371 .

9 Maurice M , Emiliani S , Dalet-Beluche I , Derancourt J , Lange R Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsomes . Eur J Biochem 1991; 200: 511-517 .

10.

10 Phillips IR , Shephard EA , Ashworth A , Rabin BR . Isolation and sequence of a human cytochrome P450 cDNA clone . Proc Natl Acad Sci USA 1985; 82: 983-987 .

11.

11 Pelkonen O , Sotaniemi EA , Ahokas JT . Coumarin 7-hydroxylase activity in human liver microsomes, properties of the enzyme and interspecies comparisons . Br J Clin Pharmacol 1985; 19: 59-66 .

12.

12 Rautio A , Kraul H , Kojo A , Salmela E , Pelkonen O Interindividual variability of coumarin 7-hydroxylation in healthy volunteers . Pharmacogenetics 1992; 2: 227-233 .

13.

13 Iscan M , Rostami H , Iscan M , Guray T , Pelkonen O , Rautio A Interindividual variability of coumarin 7-hydroxylation in Turkish population . Eur J Clin Pharmacol 1994; 47: 315-318 .

14.

14 Cholerton S , Idle ME , Vas A , Gonzales FJ , Idle JR . Comparison of a novel thin-layer chromatographic fluorescence detection method with spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine . J Chromatogr 1992; 575: 325-330 .

15.

15 Lake BG , Gaudin H , Price RJ , Walters DG . Metabolism of [3-14C I coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans . Food Chem Toxicol 1992; 30: 105-115 .

16.

16 Chen G , Tang YM , Green B , Lin DX , Guengerich FP , Daly AK , Caporaso NE , Kadlubar FF . Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method . Pharmacogenetics 1999; 9: 327-332 .

17.

17 Yamano S , Tatsuno J , Gonzalez FJ . The Cyp2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes . Biochemistry 1990; 29: 1322-1329 .

18.

18 Hadidi H , Zahlsen K , Idle JR , Cholerton S A single amino acid substitution (Leul6OHis) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin . Food Chem Toxicol 1997; 35: 903-907 .

19.

19 Fernandez-Salguero P , Hoffman SM , Cholerton S , Mohrenweiser H , Raunio, H , Rautio A , Pelkonen O , Huang JD , Evans WE , Idle JR , Gonzalez FJ . A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles . Am J Hum Genet 1995; 57: 651-660 .

20.

20 Nunoya K , Yokoi T , Takahashi Y , Kimura K , Kinoshita M , Kamataki T Homologous unequal crossover within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype . J Biochem 1999; 126: 402-407 .

21.

21 Pienezza ML , Sellers EM , Tyndale RF . Nicotine metabolism defect reduces smoking . Nature 1998; 393: 750-750 .

22.

22 Kitagawa K , Kunugita N , Katoh T , Yang M , Kawamoto T The significance of homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP . Biochem Biophys Res Commun 1999; 262: 146-151 .

23.

23 Egan DA , O'Kennedy R Rapid and sensitive determination of coumarin and 70HC and its glucoronide conjugate in urine and plasma by high-performance liquid chromatography . J Chromatogr 1992; 582: 137-143 .

24.

24 Roche D , Toury I , Lequang NT , Roussel G , Ekindjian OG . Interest of a simple mobile phase containing diethylamine acetic acid for HPLC assay of nicotine and cotinine . J Liq Chromatogr 1991; 14: 2919-2936 .

25.

25 Hadidi H , Irshaid Y , Vagbo CB , Brunsvik A , Cholerton S , Zahlsen K , Idle JR . Variability of coumarin 7-and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CY-P2A6 . Eur J Clin Pharmacol 1998; 54: 437-441 .

26.

26 London SJ , Idle JR , Daly AK , Coetzee GA . Genetic variation of CYP2A6, smoking and risk of cancer . Lancet 1999; 353: 898-899 .

27.

27 Miyamoto M , Umetsu Y , Dosaka-Akita H , Sawamura Y , Yokota J , Kunitoh H , Nemoto N , Sato K , Ariyoshi N , Kamataki T CYP2A6 gene deletion reduces susceptibility to lung cancer . Biochem Biophys Res Commun 1999; 261: 658-660 .

28.

28 Kamataki T , Nunoya K , Sakai Y , Kushida H , Fujita K Genetic polymorphism of CYP2A6 in relation to cancer . Mutat Res 1999; 428: 125-130 .

29.

29 Idle JR . CYP2A6 polymorphism, nicotine, and environmental nitrosamines . Lancet 1999; 353: 2073-2073 .

30.

30 Oke B , Lariot MA , Beaune PH , Berkkan H Microsomal epoxide hydrolase and CYP2A6 genotypes in a Turkish population . 4th Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries, Antalya, Turkey, April 12-16, 2000, p. 47-47 .